ARMH4: A Potential Drug Target and Biomarker (G145407)

Target Name: ARMH4

NCBI ID: G145407

ARMH4

ARMH4: A Potential Drug Target and Biomarker

ARMH4 (Adaptive Membrane-Spikemesh H4) is a protein that is found in various cell types, including neurons and glial cells in the central nervous system. It is characterized by its unique structure, which consists of a long arm that contains a head and a tail region, as well as a middle region that is composed of a series of spikemesh domains.

The ARMH4 protein has been shown to play a role in various cellular processes, including cell signaling, neurotransmitter release, and the regulation of cell adhesion. It is also of interest as a potential drug target and biomarker. In this article, we will discuss the ARMH4 protein, its function, potential drug targets, and its potential as a biomarker for various neurological and psychiatric disorders.

Function and Mechanism of ARMH4

The ARMH4 protein is a member of the adaptor protein family, which is involved in the regulation of protein interactions and the formation of signaling complexes. ARMH4 is characterized by its ability to form a long arm that contains a head and a tail region, as well as a middle region that is composed of a series of spikemesh domains.

The ARMH4 protein functions as a receptor for various signaling molecules, including neurotransmitters such as neurotensin, which is involved in pain signaling, and GABA, which is involved in anxiety and stress responses. When neurotransmitters bind to the ARMH4 protein, they can activate various intracellular signaling pathways, including the cAMP/cGMP signaling pathway, which is involved in neurotransmitter release.

Potential Drug Targets

The ARMH4 protein is a potential drug target due to its involvement in various cellular processes that are implicated in a variety of neurological and psychiatric disorders. One of the potential drug targets for ARMH4 is its role in pain signaling. ARMH4 has been shown to play a role in the regulation of pain transmission, and it is thought to contribute to the development and maintenance of chronic pain. Therefore, drugs that can modulate the activity of ARMH4 may be effective in treating chronic pain.

Another potential drug target for ARMH4 is its role in the regulation of neurotransmitter release. ARMH4 has been shown to play a role in the regulation of neurotransmitter release from postsynaptic neurons, and it is thought to contribute to the development of disorders such as Alzheimer's disease and Parkinson's disease. Therefore, drugs that can modulate the activity of ARMH4 may be effective in treating these disorders.

Potential Biomarkers

The ARMH4 protein is also of interest as a potential biomarker for various neurological and psychiatric disorders. The ARMH4 protein has been shown to be involved in the regulation of various cellular processes, including neurotransmitter release and cell adhesion. Therefore, changes in the level of ARMH4 protein may be a potential biomarker for a variety of neurological and psychiatric disorders.

Conclusion

In conclusion, ARMH4 is a protein that is characterized by its unique structure and its ability to form a long arm that contains a head and a tail region, as well as a middle region that is composed of a series of spikemesh domains. It is of interest as a potential drug target and biomarker for various neurological and psychiatric disorders. Further research is needed to fully understand the function and mechanism of ARMH4 and its potential as a drug target and biomarker.

Protein Name: Armadillo Like Helical Domain Containing 4

The "ARMH4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARMH4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets